Medicare Enrolled
Dr. Regina Wang, M.D.
Family Medicine · Decatur, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wang
Dr. Regina Wang is a family medicine specialist in Decatur, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wang performed 2,771 Medicare services across 870 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wang received a total of $24,606 from 61 pharmaceutical and/or device companies across 741 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in GA
$24,606 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,771
Medicare services
Top 12% in GA for family medicine
870
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~139 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,680 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
353 | $80 | $270 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
129 | $26 | $40 |
| Annual alcohol misuse screening, 5 to 15 minutes | 128 | $18 | $40 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
125 | $77 | $120 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
108 | $127 | $249 |
| Annual depression screening | 108 | $18 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
64 | $59 | $220 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
28 | $50 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $91 | $350 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
16 | $53 | $160 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
11 | $162 | $336 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,606
Total received (2018-2024)
Avg $3,515/year across 7 years
Top 1% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
741
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,855 (92.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,700 (6.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$50 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,889
2023
$2,745
2022
$3,542
2021
$5,447
2020
$2,882
2019
$3,852
2018
$3,250
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$531
AstraZeneca Pharmaceuticals LP
$448
Novo Nordisk Inc
$333
GlaxoSmithKline, LLC.
$257
ABBVIE INC.
$178
Neurocrine Biosciences, Inc.
$132
Ipsen Biopharmaceuticals, Inc
$128
IBSA Pharma Inc.
$125
EMD Serono, Inc.
$125
Janssen Pharmaceuticals, Inc
$121
Eisai Inc.
$119
Lundbeck LLC
$73
Sumitomo Pharma America, Inc.
$72
Lilly USA, LLC
$64
Esperion Therapeutics, Inc.
$44
Saluda Medical Americas, Inc.
$25
Gilead Sciences, Inc.
$22
ALK-Abello, Inc
$21
Exact Sciences Corporation
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Abbott Laboratories
$15
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$4,100
Novo Nordisk Inc
$3,100
Biohaven Pharmaceuticals, Inc.
$1,825
AstraZeneca Pharmaceuticals LP
$1,633
Lilly USA, LLC
$1,148
Amarin Pharma Inc.
$948
Gilead Sciences, Inc.
$826
PFIZER INC.
$812
ABBVIE INC.
$811
SANOFI-AVENTIS U.S. LLC
$799
AbbVie Inc.
$724
Eisai Inc.
$645
Boehringer Ingelheim Pharmaceuticals, Inc.
$512
Novartis Pharmaceuticals Corporation
$482
Kowa Pharmaceuticals America, Inc.
$471
Abbott Laboratories
$419
AbbVie, Inc.
$418
Corcept Therapeutics
$373
Janssen Pharmaceuticals, Inc
$366
Esperion Therapeutics, Inc.
$352
Lundbeck LLC
$314
GlaxoSmithKline, LLC.
$303
Radius Health, Inc.
$257
IBSA Pharma Inc.
$228
Teva Pharmaceuticals USA, Inc.
$186
EMD Serono, Inc.
$166
Allergan Inc.
$160
Bayer Healthcare Pharmaceuticals Inc.
$157
Akcea Therapeutics, Inc.
$155
Dexcom, Inc.
$143
Calliditas Therapeutics US Inc.
$132
Neurocrine Biosciences, Inc.
$132
Alexion Pharmaceuticals, Inc.
$129
Ipsen Biopharmaceuticals, Inc
$128
IMPEL PHARMACEUTICALS INC.
$127
BOSTON SCIENTIFIC CORPORATION
$120
E.R. Squibb & Sons, L.L.C.
$112
Merck Sharp & Dohme LLC
$110
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$100
Exact Sciences Corporation
$75
Sumitomo Pharma America, Inc.
$72
Currax Pharmaceuticals LLC
$66
ALK-Abello, Inc
$39
Allergan, Inc.
$39
Adhera Therapeutics, Inc.
$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$35
Merck Sharp & Dohme Corporation
$34
EISAI INC.
$30
IDORSIA PHARMACEUTICALS US INC
$30
Horizon Therapeutics plc
$25
Medicure Pharma Inc.
$25
Saluda Medical Americas, Inc.
$25
Bausch Health US, LLC
$24
Nestle HealthCare Nutrition Inc.
$23
Scilex Pharmaceuticals Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$16
Astellas Pharma US Inc
$15
ARBOR PHARMACEUTICALS, INC.
$15
Orexigen Therapeutics, Inc.
$14
Sanofi Pasteur Inc.
$13
Nalpropion Pharmaceuticals, Inc.
$13
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AIRSUPRA · AJOVY · APLENZIN · AREXVY · AUSTEDO · Aimovig · Belviq · CHANTIX · CIBINQO · CONTRAVE · CREON · Cologuard Collection Kit · Creon · DEXCOM G7 GSS (161) · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Epclusa · Evoke · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · Fycompa · GEMTESA · Grastek · Horizant · INGREZZA · INVOKANA · IQIRVO · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · LYRICA · Leqembi · Licart · LifeVest · Livalo · MAVENCLAD · MOUNJARO · MYRBETRIQ · Mavenclad · NEXLETOL · NEXLIZET · NURTEC ODT · Odactra · Otezla · Ozempic · PENNSAID · PREMARIN · PRESTALIA · Prolia · QULIPTA · QUVIVIQ · REYVOW · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SPRAVATO · STRENSIQ · SYMBICORT · Saxenda · TARPEYO · TEGSEDI · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRULICITY · Tirosint · Tresiba · Trintellix · Trudhesa · Tymlos · UBRELVY · VERQUVO · VRAYLAR · VYEPTI · Vascepa · Vemlidy · Victoza · WATCHMAN · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZENPEP · ZEPBOUND · ZTLido · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in GA.
Geographic Context
Family medicine physicians within 10 mi
1,292
Per 100K population
169.5
County median income
$77,683
Nearest hospital
EMORY DECATUR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wang is a clinical cardiology specialist, with above-average Medicare volume (top 12% in GA), with low-engagement industry engagement in the top 1% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wang experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Wang performed 1,680 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $24,606 from 61 companies across 741 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other family medicine physicians in Decatur?
Dr. Wang's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Decatur
Browse family medicine physicians in Decatur ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in GA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in GA
Which GA family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology